Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Daneels

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetics of nisoldipine in renal dysfunctionJ Boelaert, Y Valcke, H Dammekens, et al.
The New England Journal of Medicine|November 5, 1981
Renal dysfunction due to anturaneJ Boelaert, P Van Eeghem, R Daneels, et al.
Drugs|January 1, 1985
Effect of renal function and dialysis on temocillin pharmacokineticsJ Boelaert, R Daneels, M Schurgers, et al.
American Heart Journal|July 1, 1982
Renal dysfunction with sulphinpyrazone therapyJ Boelaert, P Van Eeghem, R Fagard, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1988
Itraconazole pharmacokinetics in patients with renal dysfunctionJ Boelaert, M Schurgers, E Matthys, et al.
The New England Journal of Medicine|July 3, 1980
The anturane reinfarction trialJ Boelaert, P Van Eeghem, R Daneels, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1983
The pharmacokinetics of temocillin in patients with normal and impaired renal functionJ Boelaert, R Daneels, M Schurgers, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Lean body mass and amikacin dosageT H Hallynck, H H Soep, J A Thomis, et al.
Nephrologie|January 1, 1981
[Acute renal failure induced by sulfinpyrazone (author's transl)]J Boelaert, A Meyrier, J D Sraer, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Prediction of creatinine clearance from serum creatinine concentration based on lean body massT Hallynck, H H Soep, J Thomis, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetics of nisoldipine in renal dysfunctionJ Boelaert, Y Valcke, H Dammekens, et al.
The New England Journal of Medicine|November 5, 1981
Renal dysfunction due to anturaneJ Boelaert, P Van Eeghem, R Daneels, et al.
Drugs|January 1, 1985
Effect of renal function and dialysis on temocillin pharmacokineticsJ Boelaert, R Daneels, M Schurgers, et al.
American Heart Journal|July 1, 1982
Renal dysfunction with sulphinpyrazone therapyJ Boelaert, P Van Eeghem, R Fagard, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1988
Itraconazole pharmacokinetics in patients with renal dysfunctionJ Boelaert, M Schurgers, E Matthys, et al.
The New England Journal of Medicine|July 3, 1980
The anturane reinfarction trialJ Boelaert, P Van Eeghem, R Daneels, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1983
The pharmacokinetics of temocillin in patients with normal and impaired renal functionJ Boelaert, R Daneels, M Schurgers, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Lean body mass and amikacin dosageT H Hallynck, H H Soep, J A Thomis, et al.
Nephrologie|January 1, 1981
[Acute renal failure induced by sulfinpyrazone (author's transl)]J Boelaert, A Meyrier, J D Sraer, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Prediction of creatinine clearance from serum creatinine concentration based on lean body massT Hallynck, H H Soep, J Thomis, et al.
Pageof 5